Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message| ()  

Do you prefer stocks that have been trading well recently? If so, you may like to follow stock momentum trends.

For ideas on how to start your own search, we ran a screen. We began by screening the healthcare sector for stocks that are outperforming the market, with quarterly performance above 20%.

We then screened for those with strong sales trends relative to inventory, with higher growth in revenue than inventory year-over-year, as well as inventory decreasing as a portion of current assets over the same time period.

Interactive Chart: Press Play to compare changes in market cap over the last two years for the top six stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these stocks will continue to outperform? Use this list as a starting point for your own analysis.

1. CONMED Corporation (CNMD): Provides surgical devices and equipment for minimally invasive procedures and monitoring. Performance over the last quarter at 23.31%. Revenue grew by 0.81% during the most recent quarter ($185.58M vs. $184.08M y/y). Inventory grew by -2.52% during the same time period ($168.44M vs. $172.8M y/y). Inventory, as a percentage of current assets, decreased from 49.34% to 47.22% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

2. Mine Safety Appliances Co. (MSA): Develops, manufactures, and supplies health and safety products used by workers in the fire service, homeland security, construction, and other industries, as well as the military. Performance over the last quarter at 26.43%. Revenue grew by 5.58% during the most recent quarter ($304.78M vs. $288.68M y/y). Inventory grew by -6.05% during the same time period ($141.47M vs. $150.58M y/y). Inventory, as a percentage of current assets, decreased from 31.54% to 30.83% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

3. NuVasive, Inc. (NUVA): Engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Performance over the last quarter at 52.30%. Revenue grew by 16.16% during the most recent quarter ($150.19M vs. $129.3M y/y). Inventory grew by 10.9% during the same time period ($119.31M vs. $107.58M y/y). Inventory, as a percentage of current assets, decreased from 28.94% to 20.16% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

4. Novo Nordisk A/S (NVO): Engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. Performance over the last quarter at 28.11%. Revenue grew by 12.38% during the most recent quarter ($18,120M vs. $16,124M y/y). Inventory grew by -2.64% during the same time period ($9,433M vs. $9,689M y/y). Inventory, as a percentage of current assets, decreased from 25.98% to 23.83% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

5. ResMed Inc. (RMD): Engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Performance over the last quarter at 30.05%. Revenue grew by 8.74% during the most recent quarter ($332.74M vs. $305.99M y/y). Inventory grew by -14.18% during the same time period ($184.42M vs. $214.89M y/y). Inventory, as a percentage of current assets, decreased from 18.76% to 14.79% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

6. The Spectranetics Corporation (SPNC): Designs, manufactures, and markets single use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system, the CVX-300. Performance over the last quarter at 44.40%. Revenue grew by 10.99% during the most recent quarter ($32.52M vs. $29.3M y/y). Inventory grew by 6.09% during the same time period ($8.54M vs. $8.05M y/y). Inventory, as a percentage of current assets, decreased from 13.62% to 12.43% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

7. St. Jude Medical Inc. (STJ): Develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. Performance over the last quarter at 36.63%. Revenue grew by 4.18% during the most recent quarter ($1,406.87M vs. $1,350.4M y/y). Inventory grew by -6.45% during the same time period ($624.48M vs. $667.54M y/y). Inventory, as a percentage of current assets, decreased from 22.92% to 18.42% during the most recent quarter (comparing 13 weeks ending 2011-12-31 to 13 weeks ending 2011-01-01).

8. Tornier N.V. (TRNX): Operates as a medical device company that designs, manufactures, and markets devices for joint replacement and soft tissue repair that enable surgical specialists to improve patients' lives by restoring motion and physical vitality. Performance over the last quarter at 43.03%. Revenue grew by 12.68% during the most recent quarter ($69.04M vs. $61.27M y/y). Inventory grew by 3.03% during the same time period ($79.88M vs. $77.53M y/y). Inventory, as a percentage of current assets, decreased from 44.76% to 40.17% during the most recent quarter (comparing 13 weeks ending 2012-01-01 to 13 weeks ending 2011-01-02).

9. Volcano Corporation (VOLC): Designs, develops, manufactures, and commercializes a suite of intravascular ultrasound and functional measurement products used in the diagnosis and treatment of vascular and structural heart disease. Performance over the last quarter at 31.57%. Revenue grew by 14.17% during the most recent quarter ($92.75M vs. $81.24M y/y). Inventory grew by 2.% during the same time period ($41.31M vs. $40.5M y/y). Inventory, as a percentage of current assets, decreased from 12.46% to 11.8% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

10. Waters Corp. (WAT): Designs, manufactures, sells, and services high performance liquid chromatography, ultra performance liquid chromatography, and mass spectrometry instrument systems and support products primarily in the United States, Europe, Japan, and Asia. Performance over the last quarter at 28.81%. Revenue grew by 7.82% during the most recent quarter ($521.42M vs. $483.58M y/y). Inventory grew by 4.19% during the same time period ($212.86M vs. $204.3M y/y). Inventory, as a percentage of current assets, decreased from 12.88% to 10.96% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

11. Zimmer Holdings, Inc. (ZMH): Engages in the design, development, manufacture, and marketing of orthopaedic reconstructive implants, spinal and trauma devices, dental implants, and related surgical products. Performance over the last quarter at 33.38%. Revenue grew by 2.87% during the most recent quarter ($1,167.3M vs. $1,134.7M y/y). Inventory grew by -0.7% during the same time period ($929.8M vs. $936.4M y/y). Inventory, as a percentage of current assets, decreased from 31.11% to 28.38% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

12. ZOLL Medical Corp. (ZOLL): Develops, manufactures, and markets resuscitation devices and related software solutions worldwide. Performance over the last quarter at 52.67%. Revenue grew by 18.2% during the most recent quarter ($133.75M vs. $113.16M y/y). Inventory grew by -19.84% during the same time period ($56.67M vs. $70.7M y/y). Inventory, as a percentage of current assets, decreased from 26.89% to 21.57% during the most recent quarter (comparing 13 weeks ending 2012-01-01 to 13 weeks ending 2011-01-02).

*Accounting data sourced from Google Finance, all other data sourced from Finviz.

Source: 12 Outperforming Healthcare Stocks With Encouraging Inventory Trends